Agios Pharmaceuticals Inc (AGIO)-Medical Equipment-Deals and Alliances Profile

Agios Pharmaceuticals Inc (AGIO)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME135515D
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that discovers and develops investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company's pipeline products comprise AG-221, an isocitrate dehydrogenase 2 mutant inhibitor; AG-120, an IDH1 mutant inhibitor; and AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors. It also develops AG-348 and AG-519, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. The company has collaboration with biotech companies to enhance its product candidates. Agios is headquartered in Cambridge, Massachusetts, the US.

Agios Pharmaceuticals Inc (AGIO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Agios Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Agios Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Agios Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Partnerships 10

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 10

Celgene and Agios Pharma Enter into Agreement with Abbott Labs 10

Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 11

Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 12

Equity Offering 13

Agios Pharma Completes Underwriter Exercise of Over-Allotment of Public Offering of Shares for USD287 Million 13

Agios Pharma Raises USD172.5 Million in Public Offering of Shares 15

Agios Pharmaceuticals Inc-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Strategy And Business Planning 20

Jan 11, 2016: Agios Outlines Key 2016 Goals and Priorities 20

Financial Announcements 22

May 04, 2017: Agios Reports First Quarter 2017 Financial Results 22

Feb 16, 2017: Agios Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key 2017 Milestones 24

Nov 03, 2016: Agios Reports Third Quarter 2016 Financial Results and Reviews Recent Progress in IDH and PKR Development Programs 26

Aug 04, 2016: Agios Reports Second Quarter 2016 Financial Results 28

May 05, 2016: Agios Reports First Quarter 2016 Financial Results 30

Corporate Communications 32

May 31, 2017: Agios Appoints David Scadden, M.D., to the Board of Directors 32

Jan 03, 2017: Agios Appoints Ian Clark to Board of Directors 33

Aug 16, 2016: Agios Appoints Andrew Hirsch as Chief Financial Officer 34

Feb 08, 2016: Agios Appoints Steve Hoerter as Chief Commercial Officer 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Agios Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Agios Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Agios Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

List of Tables

Agios Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 1

Agios Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Agios Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Agios Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Agios Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8

Agios Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 10

Celgene and Agios Pharma Enter into Agreement with Abbott Labs 10

Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 11

Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 12

Agios Pharma Completes Underwriter Exercise of Over-Allotment of Public Offering of Shares for USD287 Million 13

Agios Pharma Raises USD172.5 Million in Public Offering of Shares 15

Agios Pharmaceuticals Inc, Key Competitors 17

Agios Pharmaceuticals Inc, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Agios Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16553
Site License
USD 500 INR 33105
Corporate User License
USD 750 INR 49658

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com